Acasă › Leucemie mielomonocitară cronică › Texas › Houston
Studii clinice pentru Leucemie mielomonocitară cronică în Houston, TX
16 studii pentru Leucemie mielomonocitară cronică caută participanți în și în jurul orașului Houston (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
În curs de recrutareFaza 2
- The University of Texas MD Anderson Cancer Center, Houston
Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
În curs de recrutareFaza 2
- M D Anderson Cancer Center, Houston
A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
În curs de recrutareFaza 2Voluntari sănătoși bineveniți
- MD Anderson Cancer Center, Houston
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
În curs de recrutareFaza 2
- M D Anderson Cancer Center, Houston
Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia
În curs de recrutareFaza 2
- MD Anderson Cancer Center, Houston
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
În curs de recrutareFaza 2/3Voluntari sănătoși bineveniți
- M D Anderson Cancer Center, Houston
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
În curs de recrutareFaza 1/2
- M D Anderson Cancer Center, Houston
Personalized NK Cell Therapy in CBT
În curs de recrutareFaza 2
- M D Anderson Cancer Center, Houston
Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
În curs de recrutareFaza 1/2
- The University of Texas M. D. Anderson Cancer Center, Houston
A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
În curs de recrutareFaza 2
- M D Anderson Cancer Center, Houston
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
În curs de recrutareFaza 1
- M D Anderson Cancer Center, Houston
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
În curs de recrutareFaza 2/3
- MD Anderson Cancer Center, Houston
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
În curs de recrutareFaza 1/2
- M D Anderson Cancer Center, Houston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
În curs de recrutareFaza 2
- MD Anderson, Houston
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
În curs de recrutareFaza 1
- MD Anderson Cancer Center, Houston
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
În curs de recrutareFaza 1
- MD Anderson Cancer Center, Houston
Studii pentru Leucemie mielomonocitară cronică în alte orașe
- Seattle, WA10 studii
- Boston, MA7 studii
- New York City, NY6 studii
- Baldwin Park, CA6 studii
- Mountain View, CA6 studii
- Rochester, MN6 studii
- Durham, NC5 studii
- Miami, FL4 studii
- Birmingham, AL4 studii
- Tampa, FL4 studii
- Atlanta, GA4 studii
- Columbus, OH4 studii
Alte studii în Houston
- Cancer pulmonar cu celule non-pătrate145 studii
- Cancer de sân126 studii
- Cancer (toate tipurile)121 studii
- Cancer metastatic104 studii
- Cancer colorectal102 studii
- Cancer ovarian89 studii
- Leucemie mieloasă acută85 studii
- Cancer pulmonar78 studii
- Cancer de prostată76 studii
- Cancer endometrial68 studii
- Cancer pancreatic61 studii
- Melanom59 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.